total
patient
juvenil
ra
male
femal
mean
age
year
healthi
age
sexmatch
volunt
serv
control
male
femal
mean
age
year
enrol
studi
nanj
children
hospit
affili
nanj
medic
univers
patient
volunt
han
chines
patient
clinic
assess
accord
detail
diagnost
inform
obtain
medic
record
physic
examin
studi
approv
ethic
committe
nanj
medic
univers
nanj
china
method
perform
accord
relev
guidelin
regul
written
inform
consent
use
clinic
specimen
medic
research
obtain
parent
legal
guardian
particip
peripher
blood
mononuclear
cell
pbmc
studi
particip
isol
cultur
measur
express
male
mice
purchas
shanghai
slac
laboratori
anim
co
ltd
shanghai
china
mice
kept
light
temperatur
humiditycontrol
environ
constant
lightdark
cycl
access
food
water
ad
libitum
anim
procedur
studi
protocol
approv
experiment
anim
care
use
committe
nanj
medic
univers
compli
guid
care
use
laboratori
anim
nih
public
revis
bone
marrowderiv
dc
prepar
describ
briefli
bone
marrow
precursor
cell
obtain
femur
tibia
mice
cultur
fresh
dc
cultur
medium
consist
rpmi
medium
plu
granulocytemacrophag
colonystimul
factor
ngml
immunex
seattl
wa
usa
ngml
peprotech
rocki
hill
nj
usa
dc
induc
matur
lipopolysaccharid
ngml
sigmaaldrich
st
loui
mo
usa
concentr
extracellular
atp
detect
use
rluciferaseluciferin
reagent
promega
madison
wi
usa
dc
cellswel
incub
rpmi
medium
supplement
vv
fetal
bovin
serum
h
cultur
plate
aliquot
condit
medium
collect
control
sampl
baselin
atp
releas
cell
expos
bovin
cii
chondrex
redmond
wa
usa
room
temperatur
condit
medium
collect
indic
time
point
sampl
centrifug
g
min
supernat
use
atp
determin
concentr
atp
determin
measur
chemiluminescens
spectramax
luminomet
molecular
devic
downingtown
pa
usa
accord
manufactur
instruct
rna
extract
quantit
realtim
pcr
perform
gene
express
analysi
previous
briefli
total
rna
extract
cell
sampl
trizol
reagent
invitrogen
carlsbad
ca
usa
accord
manufactur
protocol
concentr
rna
sampl
determin
duplic
measur
optic
densiti
od
nm
puriti
rna
ensur
ratio
rang
rna
revers
transcrib
synthes
cdna
use
cdna
synthesi
kit
fermenta
st
leonrot
germani
one
microlit
cdna
amplifi
reaction
mixtur
reaction
perform
accord
modifi
protocol
fast
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
adopt
endogen
refer
method
use
calcul
rel
express
level
interest
gene
group
primer
sequenc
shown
supplementari
tabl
protein
extract
subject
western
blot
analysi
previous
equal
amount
protein
separ
sdspage
transfer
nitrocellulos
membran
pall
pensacola
fl
usa
semidri
blot
membran
probe
primari
antibodi
santa
cruz
biotechnolog
ca
usa
visual
use
enhanc
chemiluminesc
procedur
pierc
rockford
illinoi
usa
biomax
film
kodak
od
interest
band
normal
band
plu
softwar
singlecel
suspens
fresh
spleen
harvest
prepar
magnet
bead
separ
use
neg
isol
cell
briefli
singlecel
suspens
deplet
biotinconjug
specif
monoclon
antibodi
cell
bd
bioscienc
pharmingen
san
diego
ca
usa
antibiotin
magnet
bead
ld
magnet
bead
column
miltenyi
biotec
auburn
ca
usa
puriti
cell
consist
greater
assess
flow
cytometri
dc
cell
per
well
incub
without
two
antagonist
suramin
cultur
cell
cell
per
well
presenc
cii
h
supernat
collect
cytokin
measur
cia
induc
male
mice
previous
briefli
mice
immun
intraderm
tail
base
bovin
cii
mgml
emulsifi
complet
freund
adjuv
contain
kill
mycobacterium
tuberculosi
difco
usa
day
day
anim
boost
cii
emulsifi
incomplet
freund
adjuv
base
tail
primari
immun
day
mice
treat
antagonist
suramin
mgkg
mgkg
salin
ip
everi
week
five
week
cellfre
cultur
supernat
cocultur
system
collect
concentr
transform
growth
factor
tgf
measur
use
specif
elisa
accord
protocol
recommend
manufactur
standard
curv
gener
plate
linear
rang
use
calcul
absolut
concentr
indic
cytokin
detect
level
cell
dct
cell
cocultur
cell
incub
ngml
phorbol
myrist
acet
sigmaaldrich
st
loui
mo
usa
ionomycin
sigmaaldrich
st
loui
mo
usa
presenc
brefeldin
ebiosci
sandiego
ca
usa
h
cell
stain
ebiosci
sandiego
ca
usa
min
incub
fixationpermeabil
solut
cell
stain
ebiosci
sandiego
ca
usa
min
analyz
use
facscalibur
flow
cytomet
bd
bioscienc
cellquest
softwar
peak
cia
day
first
immun
mice
sacrif
joint
process
histopatholog
analysi
previous
joint
histolog
analyz
score
includ
synovi
hyperplasia
ii
bone
cartilag
destruct
iii
inflammatori
cell
infiltr
iv
vascular
patholog
chang
grade
base
sever
index
follow
grade
detect
chang
grade
mild
chang
grade
moder
chang
grade
sever
chang
total
histolog
score
sum
four
item
rang
spss
window
employ
data
analysi
excel
version
microsoft
also
adopt
preliminari
data
analysi
data
express
mean
se
individu
valu
comparison
two
observ
experiment
protocol
assess
student
pair
test
anova
follow
post
hoc
bonferroni
test
appli
multipl
comparison
differ
group
made
valu
p
consid
statist
signific
test
express
pbmc
patient
ra
agematch
normal
individu
use
quantit
realtim
pcr
demonstr
fig
higher
express
level
ra
group
control
group
indic
express
specif
unregul
ra
patient
investig
whether
cii
stimul
atp
releas
dc
extracellular
atp
level
cell
expos
cii
investig
respons
treatment
cii
extracellular
atp
concentr
increas
dosedepend
manner
compar
unstimul
control
fig
extracellular
atp
level
also
measur
dc
cultur
cii
h
control
well
atp
level
remain
constant
wherea
continu
treatment
increas
atp
level
fold
fig
furthermor
cii
treatment
group
exhibit
significantli
higher
level
control
group
fig
dc
cultur
treat
apyras
atp
diphosphohydrolas
uml
cii
fail
elev
level
rule
possibl
involv
endogen
atp
fig
pretreat
antagonist
suramin
abolish
promot
effect
cii
atp
releas
dc
fig
earli
stage
cultur
cell
viabil
unaffect
cii
treatment
fig
result
reveal
ciiinduc
atp
releas
dc
requir
presenc
function
preliminarili
studi
effect
three
dose
suramin
three
dose
nm
extracellular
atp
level
cocultur
system
suramin
complet
block
ciistimul
atp
secret
dose
fig
chose
lower
dose
suramin
studi
avoid
potenti
toxic
nm
could
complet
block
ciistimul
activ
fig
thu
suramin
nm
administ
follow
experi
ensur
better
competit
result
show
involv
ciiinduc
atp
releas
cell
cocultur
system
assess
role
cii
signal
cytokin
product
cell
differenti
marrowderiv
dc
cultur
presenc
cii
without
antagonist
respons
cii
treatment
found
substanti
upregul
mrna
encod
approxim
unstimul
control
fig
block
signal
dc
use
antagonist
suramin
pretreat
antagonist
caus
strong
inhibit
product
cytokin
cytokin
ciitreat
dc
confirm
requir
ciiinduc
develop
rather
microenviron
addit
determin
abil
cii
induc
cytokin
product
cell
differenti
cell
cocultur
system
cytokin
profil
ciistimul
cocultur
supernat
display
mark
alter
compar
control
found
strong
product
complet
consist
chang
trend
mrna
fig
precondit
antagonist
elimin
releasepromot
effect
cii
cytokin
effect
product
thu
data
provid
evid
support
requir
induct
microenviron
cii
addit
cii
could
stimul
product
cytokin
evalu
influenc
cii
induct
transcript
factor
essenti
cell
differenti
retino
acid
receptorrel
orphan
receptor
exposur
cii
induc
elev
mrna
encod
wherea
pretreat
antagonist
abolish
increas
fig
cii
treatment
result
substanti
upregul
mrna
fig
protein
express
fig
abrog
antagonist
moreov
cocultur
system
found
cell
significantli
increas
respons
cii
wherea
prior
exposur
antagonist
effect
cell
popul
ciistimul
subject
compar
unstimul
control
fig
similarli
mrna
fig
protein
express
fig
increas
remark
splenocyt
deriv
ciitreat
mice
consist
express
factor
increas
ciitreat
mice
fig
furthermor
cii
treatment
result
significantli
higher
percentag
cell
fig
data
signifi
cii
promot
cell
differenti
mice
howev
pretreat
antagonist
could
abolish
ciiinduc
cell
differenti
mice
investig
possibl
elev
due
direct
effect
atp
cell
induc
polar
cell
vitro
measur
mrna
protein
level
respons
mm
atp
besid
measur
express
cell
cultur
cii
h
quantit
realtim
pcr
found
cii
caus
chang
mrna
cell
compar
unstimul
control
fig
extracellular
atp
fail
induc
express
transcript
translat
level
fig
c
thu
exclud
possibl
elev
due
direct
effect
atp
cell
combin
find
believ
elev
cii
treatment
might
consequ
enhanc
express
relat
cytokin
releas
dc
compar
control
subject
higher
level
synovi
tissu
ciitreat
mice
fig
shown
fig
signific
increas
paw
oedema
record
cia
mice
rather
control
histolog
score
calcul
microphotograph
depict
fig
addit
histolog
imag
suggest
cii
lead
sever
synovi
hyperplasia
bone
cartilag
destruct
vascular
prolifer
inflammatori
cell
infiltr
fig
treatment
antagonist
effect
suppress
sever
arthriti
immun
respons
cii
result
suggest
block
signal
attenu
joint
damag
cia
mice
vivo
primari
novel
find
present
studi
involv
ciiinduc
atp
releas
dc
requir
ciiinduc
develop
microenviron
furthermor
found
cii
regul
cell
differenti
mediat
signal
vivo
vitro
block
signal
could
attenu
ciimedi
joint
damag
cia
mice
knowledg
first
studi
support
requir
regul
cell
differenti
cii
import
extracellular
signal
molecul
atp
potent
dangerassoci
molecular
pattern
molecul
may
contribut
tissu
damag
extracellular
atp
signal
act
play
import
regulatorymodulatori
role
pathogenesi
ra
patient
high
concentr
extracellular
atp
present
synovi
express
higher
monocyt
patient
ra
compar
similarli
also
observ
significantli
increas
express
ra
patient
compar
normal
counterpart
addit
defici
lead
lower
incid
lower
sever
joint
inflamm
anim
model
recent
becom
evid
involv
atp
releas
mani
type
cell
astrocyt
osteoclast
osteoblast
etc
releas
atp
via
suppos
import
sourc
extracellular
osteoclast
normal
condit
efflux
via
primari
mechan
atp
although
exactli
regul
mediat
atp
releas
cell
unclear
like
mechan
atp
releas
directli
format
membran
pore
caus
transient
activ
nowaday
signific
role
signal
therapi
ra
emerg
cia
induc
immun
emuls
complet
freund
adjuv
cii
commonli
studi
autoimmun
model
ra
identifi
potenti
pathogen
mechan
cia
resembl
mani
patholog
featur
ra
includ
synovi
hyperplasia
mononuclear
cell
infiltr
cartilag
degrad
antigendefin
model
base
cartilag
protein
cia
shortest
durat
immun
diseas
cii
major
protein
cartilag
target
tissu
presenc
tcell
bcell
immun
cii
well
establish
immunopathogenesi
firstli
investig
role
cii
atp
releas
dc
cii
dosedepend
increas
concentr
extracellular
atp
prolong
cultur
cii
result
elev
extracellular
atp
depend
independ
pathway
mayb
two
downstream
cellular
signal
mechan
propos
interestingli
also
observ
strong
promot
effect
cii
releas
atp
accompani
larg
increas
protein
level
know
involv
atp
releas
recent
report
mani
cell
test
hypothesi
function
requir
ciiinduc
atp
releas
dc
data
show
antagonist
complet
abolish
ciistimul
atp
releas
suggest
mediat
atp
releas
dc
respons
cii
effect
apyras
treatment
express
strongli
suggest
reciproc
relationship
releas
atp
function
respons
dc
cii
report
sustain
stimul
caus
phenotyp
chang
membran
permeabil
eventu
cell
observ
signific
cytotox
h
exposur
cii
particular
activ
also
contribut
cell
differenti
base
find
postul
involv
ciimedi
polar
cytokin
suffici
differenti
cell
naiv
key
player
polar
cell
toward
activ
enhanc
releas
data
add
observ
show
stimul
cii
strongli
potenti
product
mrna
absenc
signal
stimul
cii
fail
induc
upregul
cytokin
dc
previou
studi
show
stimul
bzatp
caus
influenc
releas
miller
et
found
absenc
affect
product
agreement
data
found
ciistimul
dc
lack
function
still
possess
abil
promot
product
contrast
absenc
affect
differ
find
current
studi
specul
differ
medium
measur
two
studi
may
explain
discrep
notabl
result
indic
requir
ciiinduc
develop
rather
microenviron
interestingli
studi
vergani
et
found
vitro
genet
upregul
pathway
shown
stimul
cell
gener
find
suggest
may
differ
role
differenti
cell
certain
circumst
cocultur
system
cell
dc
wide
use
studi
mechan
underli
polar
naiv
cell
thu
investig
potenti
role
cell
differenti
cocultur
system
consist
mrna
find
block
signal
similar
influenc
cytokin
profil
ciistimul
cocultur
supernat
elisa
result
enhanc
find
necessari
ciimedi
cell
differenti
extracellular
atp
signal
act
complex
dynam
previou
studi
show
atp
stimul
strongli
induc
express
transcript
translat
subsequ
pore
form
respons
activ
induc
addit
atp
releas
initi
posit
feedback
result
vitro
experi
found
reciproc
relationship
atp
releas
function
respons
cii
ciiinduc
activ
promot
atp
releas
via
format
membran
pore
meanwhil
intensifi
stimul
atp
enhanc
express
dynam
associ
atp
releas
express
strengthen
function
challeng
cii
previous
report
atp
activ
induc
cytokin
respons
inflammatori
work
explor
releas
six
inflammatori
cytokin
dc
respons
cii
consider
research
effort
focus
possibl
mechan
downstream
induct
inflammatori
cytokin
includ
inflammasomedepend
pkcmapk
signal
pathway
mapk
pathway
collect
believ
activ
downstream
signal
axi
like
respons
releas
inflammatori
cytokin
induc
cii
studi
need
elucid
signal
pathway
releas
inflammatori
cytokin
induc
cii
given
signal
facilit
develop
cytokin
milieu
import
cell
differenti
investig
influenc
express
essenti
cell
firstli
report
mrna
level
profoundli
elev
follow
stimul
cii
furthermor
fail
observ
upregul
mrna
encod
cocultur
system
blockad
hint
could
posit
regul
express
block
signal
abolish
ciimedi
increas
importantli
chang
observ
respons
cii
proport
cell
treatment
antagonist
compar
unstimul
control
prove
suffici
direct
evid
necessari
compon
ciiinduc
differenti
cell
analysi
spleen
cell
cia
mice
show
chang
trend
indic
cell
differenti
base
find
propos
cii
promot
differenti
cell
via
signal
vivo
vitro
interestingli
recent
studi
suggest
possibl
involv
b
cell
product
schlegel
et
demonstr
addit
cell
substanti
number
innat
adapt
immun
cell
particular
also
b
cell
particip
product
establish
ra
anoth
studi
also
identifi
b
cell
major
sourc
rapid
innatelik
product
vivo
respons
trypanosoma
cruzi
express
cell
immun
system
includ
cell
b
howev
still
unknown
whether
antagonist
effect
specif
cell
rather
b
cell
specul
possibl
antagonist
induc
inhibit
cell
b
cell
may
work
simultan
abolish
ciimedi
increas
vivo
consid
posit
effect
signal
differenti
cell
next
examin
whether
inhibit
attenu
ciimedi
joint
damag
cia
mice
result
indic
blockad
remark
inhibit
hind
paw
swell
amelior
patholog
chang
ankl
joint
cia
mice
result
clearli
suggest
might
interest
target
clinic
treatment
ra
sinc
blockad
attenu
differenti
cell
promot
cii
vivo
vitro
applic
therapeut
regimen
target
investig
recent
recogn
gmcsf
potenti
amelior
autoimmun
diseas
induc
natur
treg
previous
review
although
block
gmcsf
receptor
regard
avail
potent
antiinflammatori
therapi
gmcsf
act
antiinflammatoryregulatori
cytokin
mani
increas
regulatori
tcell
number
function
modul
differenti
interestingli
gathungu
et
demonstr
elev
gmcsf
autoantibodi
risk
marker
aggress
crohn
diseas
behavior
complic
includ
surgeri
indic
defici
gmcsf
contribut
rel
immunodefici
case
report
rowin
et
reveal
gmcsf
treatment
lead
sustain
increas
express
enhanc
capabl
treg
limit
prolif
capac
effector
cell
studi
show
present
posit
effect
differenti
cell
proinflammatori
role
inhibit
attenu
joint
damag
cia
mice
given
opposit
effect
gmcsf
regul
balanc
postul
gmcsf
may
possibl
affect
express
henc
attenu
cia
experi
need
test
hypothesi
addit
induct
cia
cii
prove
capabl
gener
eyemedi
immun
acaidmedi
immun
emerg
novel
antiinflammatori
therapeut
target
variou
select
antagonist
clinic
trial
view
potenti
role
regul
inflamm
report
studi
previou
believ
may
central
role
immun
toler
could
therapeut
implic
rout
immun
toler
cii
involv
summari
demonstr
novel
function
signal
regul
ciiinduc
differenti
cell
signal
facilit
develop
sophist
network
dcderiv
cytokin
favor
phenotyp
dc
critic
import
immunotherapi
may
becom
interest
target
dcbase
therapeut
approach
fortun
sever
potent
antagonist
avail
could
help
drug
screen
manag
patient
ra
cite
articl
fan
zd
et
al
involv
receptor
signal
regul
differenti
cell
type
ii
collageninduc
arthriti
mice
sci
rep
doi
